Are cultured mesenchymal stromal cells an option for immunomodulation in transplantation?

Frontiers in Immunology

Volumn 4, Issue FRB, 2013, Pages

  Plock, Jan A ^a,b   Schnider, Jonas T ^a,b   Schweizer, Riccardo ^a,b   Gorantla, Vijay S ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONFOCAL LASER MICROSCOPY; FLUORESCENCE MICROSCOPY; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; KIDNEY FUNCTION; MESENCHYMAL STROMA CELL; MORTALITY; NONHUMAN; NOTE; PROTEIN EXPRESSION; TREATMENT OUTCOME;

EID: 84880823501     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00041     Document Type: Note

References (17)

1. Banfi, A., Bianchi, G., Notaro, R., Luzzatto, L., Cancedda, R., and Quarto, R. (2002). Replicative aging and gene expression in long-term cultures of human bone marrow stromal cells. Tissue Eng. 8, 901-910.
2. Bernardo, M. E., Ball, L. M., Cometa, A. M., Roelofs, H., Zecca, M., Avanzini, M. A., et al. (2010). Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation. Bone Marrow Transplant. 46, 200-207.
3. Dander, E., Lucchini, G., Vinci, P., Introna, M., Masciocchi, F., Perseghin, P., et al. (2012). Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring. Leukemia 26, 1681-1684.
4. de Girolamo, L., Lucarelli, E., Alessandri, G., Avanzini, M. A., Bernardo, M. E., Biagi, E., et al. (2012). Mesenchymal stem/stromal cells: a new "cells as drugs" paradigm. Efficacy and critical aspects in cell therapy. Curr. Pharm. Des. [Epub ahead of print].
5. Eggenhofer, E., Benseler, V., Kroemer, A., Popp, F. C., Geissler, E. K., Schlitt, H. J., et al. (2012). Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion. Front. Immun. 3:297. doi: 10.3389/fimmu.2012.00297
6. Fischer, U. M., Harting, M. T., Jimenez, F., Monzon-Posadas, W. O., Xue, H., Savitz, S. I., et al. (2009). Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev. 18, 683-692.
7. Hematti, P. (2012). Mesenchymal stromal cells and fibroblasts: a case of mistaken identity?. Cytotherapy 14, 516-521.
8. Kuo, Y.-R., Chen, C.-C., Goto, S., Lee, I.-T., Huang, C.-W., Tsai, C.-C., et al. (2011). Modulation of immune response and t-cell regulation by donor adipose-derived stem cells in a rodent hind-limb allotransplant model. Plast. Reconstr. Surg. 128, 661e-672e.
9. Kuo, Y.-R., Goto, S., Shih, H.-S., Wang, F.-S., Lin, C.-C., Wang, C.-T., et al. (2009). Mesenchymal stem cells prolong composite tissue allotransplant survival in a swine model. Transplantation 87, 1769-1777.
10. Pan, H., Zhao, K., Wang, L., Zheng, Y., Zhang, G., Mai, H., et al. (2010). Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation. J. Surg. Res. 160, 315-324.
11. Parekkadan, B., and Milwid, J. M. (2010). Mesenchymal stem cells as therapeutics. Annu. Rev. Biomed. Eng. 12, 87-117.
12. Rombouts, W. J. C., and Ploemacher, R. E. (2003). Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture. Leukemia 17, 160-170.
13. Schlosser, S., Dennler, C., Schweizer, R., Eberli, D., Stein, J. V., Enzmann, V., et al. (2012). Paracrine effects of mesenchymal stem cells enhance vascular regeneration in ischemic murine skin. Microvasc. Res. 83, 267-275.
14. Vacanti, V., Kong, E., Suzuki, G., Sato, K., Canty, J. M., and Lee, T. (2005). Phenotypic changes of adult porcine mesenchymal stem cells induced by prolonged passaging in culture. J. Cell. Physiol. 205, 194-201.
15. Wagner, W., Ho, A. D., and Zenke, M. (2010). Different facets of aging in human mesenchymal stem cells. Tissue Eng. Part B Rev. 16, 445-453.
16. Zanotti, L., Sarukhan, A., Dander, E., Castor, M., Cibella, J., Soldani, C., et al. (2013). Encapsulated mesenchymal stem cells for in vivo immunomodulation. Leukemia 27, 500-503.
17. Zonta, S., De Martino, M., Bedino, G., Piotti, G., Rampino, T., Gregorini, M., et al. (2010). Which is the most suitable and effective route of administration for mesenchymal stem cell-based immunomodulation therapy in experimental kidney transplantation: endovenous or arterial? Transplant. Proc. 42, 1336-1340.